Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Cardiologia (Rome, Italy)
|
December 1, 1994
[Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease]
B Magnani, F Semprini
European Heart Journal
|
July 1, 1990
Comparative haemodynamic effects of transdermal vs intravenous nitroglycerin in acute myocardial infarction with elevated pulmonary artery wedge pressure
G Melandri, F Semprini, A Branzi, et al.
Cardiologia (Rome, Italy)
|
July 1, 1988
[Indications for surgical correction of chronic mitral insufficiency]
A Branzi, G Piovaccari, W Colazzo, et al.
Thrombosis Research
|
May 1, 1992
Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction
G Melandri, A Branzi, F Semprini, et al.
Cardiologia (Rome, Italy)
|
December 1, 1994
[Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment]
G Melandri, F Semprini, V Cervi, et al.
International Journal of Cardiology
|
May 18, 1999
Long-term arterial patency after coronary reperfusion
A Branzi, G Melandri, F Semprini, et al.
British Heart Journal
|
August 1, 1990
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin
G Melandri, A Branzi, F Semprini, et al.
International Journal of Cardiology
|
December 1, 1992
Spontaneous superoxide generation by polymorphonuclear leukocytes isolated from patients with stable angina after physical exercise
C Guarnieri, G Melandri, I Caldarera, et al.
The American Journal of Cardiology
|
February 15, 1993
On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes
G Melandri, A Branzi, A M Traini, et al.
The American Journal of Cardiology
|
August 15, 1993
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects
G Melandri, F Semprini, V Cervi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Cardiologia (Rome, Italy)
|
December 1, 1994
[Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease]
B Magnani, F Semprini
European Heart Journal
|
July 1, 1990
Comparative haemodynamic effects of transdermal vs intravenous nitroglycerin in acute myocardial infarction with elevated pulmonary artery wedge pressure
G Melandri, F Semprini, A Branzi, et al.
Cardiologia (Rome, Italy)
|
July 1, 1988
[Indications for surgical correction of chronic mitral insufficiency]
A Branzi, G Piovaccari, W Colazzo, et al.
Thrombosis Research
|
May 1, 1992
Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction
G Melandri, A Branzi, F Semprini, et al.
Cardiologia (Rome, Italy)
|
December 1, 1994
[Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment]
G Melandri, F Semprini, V Cervi, et al.
International Journal of Cardiology
|
May 18, 1999
Long-term arterial patency after coronary reperfusion
A Branzi, G Melandri, F Semprini, et al.
British Heart Journal
|
August 1, 1990
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin
G Melandri, A Branzi, F Semprini, et al.
International Journal of Cardiology
|
December 1, 1992
Spontaneous superoxide generation by polymorphonuclear leukocytes isolated from patients with stable angina after physical exercise
C Guarnieri, G Melandri, I Caldarera, et al.
The American Journal of Cardiology
|
February 15, 1993
On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes
G Melandri, A Branzi, A M Traini, et al.
The American Journal of Cardiology
|
August 15, 1993
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects
G Melandri, F Semprini, V Cervi, et al.
Page
of 2